Two software tools that improve identification of cancer biomarkers earn certification
Tuesday, August 18, 2009 - 12:07
in Health & Medicine
The explosive growth of genomic and proteomic data has ushered in a new era of molecular medicine in which cancer detection, diagnosis and treatment are tailored to each individual's molecular profile. But this personalized medicine approach requires that researchers discover and link biomarkers -- such as genes or proteins -- to specific disease behaviors, such as the rate of tumor progression and different responses to treatments.